Inspire MD (NSPR -14%) gets smacked down today, flying in the face of largely posititve results...

|By:, SA News Editor

Inspire MD (NSPR -14%) gets smacked down today, flying in the face of largely posititve results from six-month trials of its MGuard Embolic Protection Stent that showed a lower mortality rate. The MGuard EPS uses a micro-net mesh sleeve to prevent unstable arterial plaque and clots that cause heart attack blockage from breaking off and exacerbating damage.